Marinus Pharmaceuticals IncEigentümerstruktur
| Preis (2025-02-11) | 52W Hoch | 52W Tief |
| 0.55 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1,067 USD | 1 | 0 | 6 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 55.218.500 | 10,32 | 1,09 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Marinus Pharmaceuticals Inc
Mitarbeiter 165
Handelsplatz NASDAQ
Ticker Symbol MRNS
IPO Datum 2014-07-31
Adresse 5 Radnor Corporate Center, Radnor, PA, United States, 19087
Webseite https://marinuspharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Scott N. Braunstein M.D. | CEO, President & Chairman |
| 2 | Mr. Steven E. Pfanstiel C.M.A., M.B.A. | COO, CFO & Treasurer |
| 3 | Dr. Joseph Hulihan M.D. | Chief Medical Officer |
| 4 | Dr. Alex Aimetti Ph.D. | Chief Scientific Officer |
| 5 | Ms. Sonya Weigle | Senior VP of Investor Relations, Human Resources & Corporate Affairs |
| 6 | Ms. Martha E. Manning Esq., J. D. | Senior VP, General Counsel & Secretary |
| 7 | Molly Cameron | Director of Corporate Communications & Investor Relations |
| 8 | Dr. Kimberly A. McCormick Pharm.D. | Chief Regulatory & Quality Assurance Officer |
| 9 | Ms. Christina Shafer | Chief Commercial Officer |
| 10 | Mr. David Czekai | Chief Chemistry, Manufacturing & Controls Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Beryl Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 2 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 3 | ODDO BHF Asset Management SAS | 0,00% | 0,00 Mio. USD |
| 4 | Bain Capital Life Sciences Investors, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Aberdeen Group PLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 8 | GSA Capital Partners LLP | 0,00% | 0,00 Mio. USD |
| 9 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 10 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 13 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 14 | Prudential Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 15 | Schroder Investment Management Group | 0,00% | 0,00 Mio. USD |
| 16 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 17 | Royal Bank of Canada | 0,00% | 0,00 Mio. USD |
| 18 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 20 | XTX Topco Ltd | 0,00% | 0,00 Mio. USD |